Therapy Insight: potential of statins for cancer chemoprevention and therapy
Matthew S Katz
Correspondence Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Email mskatz@partners.org
Statins are commonly prescribed to treat dyslipidemia and to prevent coronary artery disease, but studies also indicate their potential for cancer prevention. Preclinical data suggest pleiotropic antineoplastic effects of statins, but clinical data assessing cancer risk associated with statin use are conflicting. This review critically discusses the existing evidence highlighting the role of statins for cancer chemoprevention.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCAKidney International Original Article
See all 31 matches for Research